Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Current Leases (2019 - 2025)

Pulmonx has reported Current Leases over the past 7 years, most recently at $1.2 million for Q4 2025.

  • Quarterly Current Leases rose 55.53% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 55.53% year-over-year, with the annual reading at $1.2 million for FY2025, 55.53% up from the prior year.
  • Current Leases was $1.2 million for Q4 2025 at Pulmonx, up from $1.1 million in the prior quarter.
  • Over five years, Current Leases peaked at $3.4 million in Q3 2023 and troughed at $663000.0 in Q3 2024.
  • The 5-year median for Current Leases is $2.1 million (2021), against an average of $2.1 million.
  • Year-over-year, Current Leases soared 80.91% in 2022 and then crashed 80.7% in 2024.
  • A 5-year view of Current Leases shows it stood at $2.2 million in 2021, then surged by 46.71% to $3.2 million in 2022, then dropped by 4.8% to $3.1 million in 2023, then tumbled by 74.69% to $778000.0 in 2024, then surged by 55.53% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Current Leases are $1.2 million (Q4 2025), $1.1 million (Q3 2025), and $1.1 million (Q2 2025).